Skip to Content
Merck
CN
  • Combination Therapy of Olmesartan and Azelnidipine Inhibits Sympathetic Activity Associated with Reducing Oxidative Stress in the Brain of Hypertensive Rats

Combination Therapy of Olmesartan and Azelnidipine Inhibits Sympathetic Activity Associated with Reducing Oxidative Stress in the Brain of Hypertensive Rats

Clinical and Experimental Hypertension (2012)
Shinohara, K., et al.